Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction.
D000208:Acute Disease; D000787:Angina Pectoris / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D005230:Fatty Acids, Nonesterified; D005947:Glucose / Q000009:adverse effects / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality; D009206:Myocardium / Q000378:metabolism; D010101:Oxygen Consumption; D011188:Potassium / Q000009:adverse effects / Q000627:therapeutic use*; D012996:Solutions
D005230:Fatty Acids, Nonesterified; D007328:Insulin; D012996:Solutions; C030396:glucose-insulin-potassium cardioplegic solution; D005947:Glucose; D011188:Potassium